Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting β2-agonist: A cost-effectiveness analysis.

Pediatric pulmonology - 1 Oct 2024

Buendía Jefferson Antonio, Salazar Andrés Felipe Zuluaga

Abstract excerpt

INTRODUCTION: Predicting response to inhaled corticosteroids (ICSs) + long-acting β2-agonist (LABA) by previously detecting the presence of Arg16Gly ADRB2 genotype is a strategy that could reduce and optimize the management of asthmatic patients. There is a need for economic evaluations to facilitate the implementation of such tests. This research aims to evaluate the cost-effectiveness of Arg16Gly ADRB2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adrenergic beta-2 Receptor Agonists

Share to Anti-Asthmatic Agents

Share to Colombia

Share to Cost-Benefit Analysis

Share to Quality-Adjusted Life Years

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 38661231
DOI: 10.1002/ppul.27037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting β2-agonist: A cost-effectiveness analysis.PMID 38661231Read ↗

Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.Semantic proximity Read ↗

Tailored second-line therapy in asthmatic children with the Arg(16) genotype.Semantic proximity Read ↗

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read ↗

β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.Semantic proximity Read ↗

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.Semantic proximity Read ↗

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.Semantic proximity Read ↗

Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Predicting inhaled corticosteroid response in asthma with two associated SNPs.Semantic proximity Read ↗

Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.Semantic proximity Read ↗

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.Semantic proximity Read ↗

Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.